Review of CHAARTED Trial Results

Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Expanded access in North America

Dr. Shore recently completed attendance at the Advanced Prostate Cancer Consensus Conference: APCCC in St. Gallen, Switzerland last week